Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 36544 [2012-14922]
Download as PDF
<![CDATA[
36544
Federal Register / Vol. 77, No. 118 / Tuesday, June 19, 2012 / Notices
hazards to which they may be exposed;
(2) Relative symptoms and appropriate
emergency treatment; and (3) Proper
conditions and precautions for safe use
and exposure.
B. Annual Reporting Burden
Respondents: 563.
Responses per Respondent: 3.
Hours per Response: .658.
Total Burden Hours: 1111.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the General Services Administration,
Regulatory Secretariat, 1275 First Street
NE., Washington, DC 20417, telephone
(202) 501–4755. Please cite OMB
Control No. 3090–0205, Environmental
Conservation, Occupational Safety, and
Drug-Free Workplace, in all
correspondence.
Dated: June 11, 2012.
Joseph A. Neurauter,
Director, Office of Acquisition Policy, Senior
Procurement Executive.
[FR Doc. 2012–14836 Filed 6–18–12; 8:45 am]
BILLING CODE 6820–61–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
srobinson on DSK4SPTVN1PROD with NOTICES
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0547]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Survey on the
Occurrence of Foodborne Illness Risk
Factors in Selected Retail and
Foodservice Facility Types (2013–
2022)
ACTION:
The meeting announced below
concerns Coordinating Center for
Research and Training to Promote the
Health of People with Developmental
and Other Disabilities, FOA DD12–006,
initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 11:00 a.m.–3:00 p.m., July
10, 2012 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Coordinating Center for
Research and Training to Promote the Health
of People with Developmental and Other
Disabilities, FOA DD12–006, initial review.’’
Contact Person for More Information:
M. Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Jkt 226001
[FR Doc. 2012–14922 Filed 6–18–12; 8:45 am]
Food and Drug Administration,
HHS.
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
16:39 Jun 18, 2012
Dated: June 13, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
AGENCY:
Centers for Disease Control and
Prevention
VerDate Mar<15>2010
Mailstop F–46, Atlanta, Georgia 30341,
Telephone: (770) 488–3585.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
a survey entitled ‘‘Occurrence of
Foodborne Illness Risk Factors in
Selected Retail and Foodservice Facility
Types (2013–2022).’’
DATES: Submit written or electronic
comments on the collection of
information by August 20, 2012.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
SUMMARY:
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
Ila
S. Mizrachi, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
7726, Ila.Mizrachi@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
FOR FURTHER INFORMATION CONTACT:
Survey on the Occurrence of Foodborne
Illness Risk Factors in Selected Retail
and Foodservice Facility Types (2013–
2022)—(OMB Control Number 0910–
NEW)
I. Background
In 1998, the U.S. Food and Drug
Administration’s National Retail Food
Team initiated a 10-year voluntary
survey to measure trends in the
occurrence of foodborne illness risk
factors—preparation practices and
employee behaviors most commonly
reported to the Centers for Disease
Control and Prevention (CDC) as
contributing factors to foodborne illness
outbreaks at the retail level.
Specifically, the survey included data
collection inspections of various types
E:\FR\FM\19JNN1.SGM
19JNN1
]]>Agencies
[Federal Register Volume 77, Number 118 (Tuesday, June 19, 2012)]
[Notices]
[Page 36544]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-14922]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Coordinating Center for
Research and Training to Promote the Health of People with
Developmental and Other Disabilities, FOA DD12-006, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 11:00 a.m.-3:00 p.m., July 10, 2012 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Coordinating Center for Research and Training to
Promote the Health of People with Developmental and Other
Disabilities, FOA DD12-006, initial review.''
Contact Person for More Information: M. Chris Langub, Ph.D.,
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-
46, Atlanta, Georgia 30341, Telephone: (770) 488-3585.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: June 13, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-14922 Filed 6-18-12; 8:45 am]
BILLING CODE 4163-18-P
